-
1
-
-
70450189795
-
Inflammation in Atherosclerosis. From Pathophysiology to Practice
-
2-s2.0-70450189795 10.1016/j.jacc.2009.09.009
-
Libby P., Ridker P. M., Hansson G. K., Inflammation in Atherosclerosis. From Pathophysiology to Practice. Journal of the American College of Cardiology 2009 54 23 2129 2138 2-s2.0-70450189795 10.1016/j.jacc.2009.09.009
-
(2009)
Journal of the American College of Cardiology
, vol.54
, Issue.23
, pp. 2129-2138
-
-
Libby, P.1
Ridker, P.M.2
Hansson, G.K.3
-
2
-
-
77953799874
-
Biomarkers of inflammation and oxidative stress in atherosclerosis
-
2-s2.0-77953799874 10.2217/bmm.10.57
-
Uno K., Nicholls S. J., Biomarkers of inflammation and oxidative stress in atherosclerosis. Biomarkers in Medicine 2010 4 3 361 373 2-s2.0-77953799874 10.2217/bmm.10.57
-
(2010)
Biomarkers in Medicine
, vol.4
, Issue.3
, pp. 361-373
-
-
Uno, K.1
Nicholls, S.J.2
-
3
-
-
70349435655
-
Association of inflammatory markers with angiographic severity and extent of coronary artery disease
-
2-s2.0-70349435655 10.1016/j.atherosclerosis.2009.01.041
-
Drakopoulou M., Toutouzas K., Stefanadi E., Tsiamis E., Tousoulis D., Stefanadis C., Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis 2009 206 2 335 339 2-s2.0-70349435655 10.1016/j.atherosclerosis.2009.01.041
-
(2009)
Atherosclerosis
, vol.206
, Issue.2
, pp. 335-339
-
-
Drakopoulou, M.1
Toutouzas, K.2
Stefanadi, E.3
Tsiamis, E.4
Tousoulis, D.5
Stefanadis, C.6
-
4
-
-
63049117088
-
Interactions between Advanced Glycation End-products (AGE) and their receptors in the development and progression of diabetic nephropathy - Are these receptors valid therapeutic targets
-
2-s2.0-63049117088 10.2174/138945009787122905
-
Sourris K. C., Forbes J. M., Interactions between Advanced Glycation End-products (AGE) and their receptors in the development and progression of diabetic nephropathy-are these receptors valid therapeutic targets. Current Drug Targets 2009 10 1 42 50 2-s2.0-63049117088 10.2174/138945009787122905
-
(2009)
Current Drug Targets
, vol.10
, Issue.1
, pp. 42-50
-
-
Sourris, K.C.1
Forbes, J.M.2
-
5
-
-
0032029363
-
AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
-
DOI 10.1016/S0008-6363(97)00233-2, PII S0008636397002332
-
Bierhaus A., Hofmann M. A., Ziegler R., Nawroth P. P., AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovascular Research 1998 37 3 586 600 2-s2.0-0032029363 10.1016/S0008-6363(97)00233-2 (Pubitemid 28231153)
-
(1998)
Cardiovascular Research
, vol.37
, Issue.3
, pp. 586-600
-
-
Bierhaus, A.1
Hofmann, M.A.2
Ziegler, R.3
Nawroth, P.P.4
-
6
-
-
69249100372
-
RAGE: Therapeutic target and biomarker of the inflammatory response - The evidence mounts
-
2-s2.0-69249100372 10.1189/jlb.0409230
-
Ramasamy R., Yan S. F., Schmidt A. M., RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts. Journal of Leukocyte Biology 2009 86 3 505 512 2-s2.0-69249100372 10.1189/jlb.0409230
-
(2009)
Journal of Leukocyte Biology
, vol.86
, Issue.3
, pp. 505-512
-
-
Ramasamy, R.1
Yan, S.F.2
Schmidt, A.M.3
-
7
-
-
10744229528
-
The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins: A Novel Pathway for Inflammatory Cell Recruitment
-
DOI 10.1084/jem.20030800
-
Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., Nagashima M., Morser J., Arnold B., Preissner K. T., Nawroth P. P., The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. Journal of Experimental Medicine 2003 198 10 1507 1515 2-s2.0-10744229528 10.1084/jem.20030800 (Pubitemid 37467165)
-
(2003)
Journal of Experimental Medicine
, vol.198
, Issue.10
, pp. 1507-1515
-
-
Chavakis, T.1
Bierhaus, A.2
Al-Fakhri, N.3
Schneider, D.4
Witte, S.5
Linn, T.6
Nagashima, M.7
Morser, J.8
Arnold, B.9
Preissner, K.T.10
Nawroth, P.P.11
-
8
-
-
66949157648
-
RAGE: A novel biological and genetic marker for vascular disease
-
2-s2.0-66949157648 10.1042/CS20080494
-
Kalea A. Z., Schmidt A. M., Hudson B. I., RAGE: a novel biological and genetic marker for vascular disease. Clinical Science 2009 116 8 621 637 2-s2.0-66949157648 10.1042/CS20080494
-
(2009)
Clinical Science
, vol.116
, Issue.8
, pp. 621-637
-
-
Kalea, A.Z.1
Schmidt, A.M.2
Hudson, B.I.3
-
9
-
-
65349167787
-
The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease
-
2-s2.0-65349167787 10.1017/S146239940900101X
-
Yan S. F., Ramasamy R., Schmidt A. M., The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease. Expert reviews in molecular medicine 2009 11 e9 2-s2.0-65349167787 10.1017/S146239940900101X
-
(2009)
Expert Reviews in Molecular Medicine
, vol.11
-
-
Yan, S.F.1
Ramasamy, R.2
Schmidt, A.M.3
-
10
-
-
0013615899
-
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
-
DOI 10.1038/382685a0
-
Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A. M., RAGE and amyloid- β peptide neurotoxicity in Alzheimer's disease. Nature 1996 382 6593 685 691 2-s2.0-0013615899 10.1038/382685a0 (Pubitemid 26282167)
-
(1996)
Nature
, vol.382
, Issue.6593
, pp. 685-691
-
-
Yan, S.D.1
Chen, X.2
Fu, J.3
Chen, M.4
Zhu, H.5
Roher, A.6
Slattery, T.7
Zhao, L.8
Nagashima, M.9
Morser, J.10
Migheli, A.11
Nawroth, P.12
Stern, D.13
Schmidt, A.M.14
-
11
-
-
0033603241
-
RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides
-
DOI 10.1016/S0092-8674(00)80801-6
-
Hofmann M. A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M. F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A. M., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999 97 7 889 901 2-s2.0-0033603241 10.1016/S0092-8674(00) 80801-6 (Pubitemid 29375048)
-
(1999)
Cell
, vol.97
, Issue.7
, pp. 889-901
-
-
Hofmann, M.A.1
Drury, S.2
Fu, C.3
Qu, W.4
Taguchi, A.5
Lu, Y.6
Avila, C.7
Kambham, N.8
Bierhaus, A.9
Nawroth, P.10
Neurath, M.F.11
Slattery, T.12
Beach, D.13
McClary, J.14
Nagashima, M.15
Morser, J.16
Stern, D.17
Schmidt, A.M.18
-
12
-
-
0028851635
-
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system
-
2-s2.0-0028851635 10.1074/jbc.270.43.25752
-
Hori O., Brett J., Slattery T., Cao R., Zhang J., Jing Xian Chen J. X. C., Nagashima M., Lundh E. R., Vijay S., Nitecki D., Morser J., Stern D., Schmidt A. M., The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. Journal of Biological Chemistry 1995 270 43 25752 25761 2-s2.0-0028851635 10.1074/jbc.270.43.25752
-
(1995)
Journal of Biological Chemistry
, vol.270
, Issue.43
, pp. 25752-25761
-
-
Hori, O.1
Brett, J.2
Slattery, T.3
Cao, R.4
Zhang, J.5
Jing Xian Chen, J.X.C.6
Nagashima, M.7
Lundh, E.R.8
Vijay, S.9
Nitecki, D.10
Morser, J.11
Stern, D.12
Schmidt, A.M.13
-
13
-
-
0034682315
-
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
-
DOI 10.1038/35012626
-
Taguchi A., Blood D. C., del Toro G., Canet A., Lee D. C., Qu W., Tanjl N., Lu Y., Lalla E., Fu C., Hofmann M. A., Kislinger T., Ingram M., Lu A., Tanaka H., Hori O., Ogawa S., Stern D. M., Schmidt A. M., Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000 405 6784 354 360 2-s2.0-0034682315 10.1038/35012626 (Pubitemid 30337069)
-
(2000)
Nature
, vol.405
, Issue.6784
, pp. 354-360
-
-
Taguchi, A.1
Blood, D.C.2
Del Toro, G.3
Canet, A.4
Lee, D.C.5
Qu, W.6
Tanjl, N.7
Lu, Y.8
Lalla, E.9
Fu, C.10
Hofmann, M.A.11
Kislinger, T.12
Ingram, M.13
Lu, A.14
Tanaka, H.15
Hori, O.16
Ogawa, S.17
Stern, D.M.18
Schmidt, A.M.19
-
14
-
-
20444426542
-
Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
-
Dumitriu I. E., Baruah P., Valentinis B., Voll R. E., Herrmann M., Nawroth P. P., Arnold B., Bianchi M. E., Manfredi A. A., Rovere-Querini P., Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. Journal of Immunology 2005 174 12 7506 7515 2-s2.0-20444426542 (Pubitemid 40806253)
-
(2005)
Journal of Immunology
, vol.174
, Issue.12
, pp. 7506-7515
-
-
Dumitriu, I.E.1
Baruah, P.2
Valentinis, B.3
Voll, R.E.4
Herrmann, M.5
Nawroth, P.P.6
Arnold, B.7
Bianchi, M.E.8
Manfredi, A.A.9
Rovere-Querini, P.10
-
15
-
-
84885666326
-
Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases
-
Mahajan N., Dhawan V., Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases. International Journal of Cardiology 2013 5273 13 00922 00924
-
(2013)
International Journal of Cardiology
, vol.5273
, Issue.13
, pp. 00922-00924
-
-
Mahajan, N.1
Dhawan, V.2
-
17
-
-
78650853295
-
Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes
-
2-s2.0-78650853295 10.1042/CS20100256
-
Tam X. H. L., Shiu S. W. M., Leng L., Bucala R., Betteridge D. J., Tan K. C. B., Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes. Clinical Science 2011 120 2 81 89 2-s2.0-78650853295 10.1042/CS20100256
-
(2011)
Clinical Science
, vol.120
, Issue.2
, pp. 81-89
-
-
Tam, X.H.L.1
Shiu, S.W.M.2
Leng, L.3
Bucala, R.4
Betteridge, D.J.5
Tan, K.C.B.6
-
18
-
-
0030061699
-
Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats
-
2-s2.0-0030061699
-
Wautier J.-L., Zoukourian C., Chappey O., Wautier M.-P., Guillausseau P.-J., Cao R., Horl O., Stern D., Schmidt A. M., Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. Journal of Clinical Investigation 1996 97 1 238 243 2-s2.0-0030061699
-
(1996)
Journal of Clinical Investigation
, vol.97
, Issue.1
, pp. 238-243
-
-
Wautier, J.-L.1
Zoukourian, C.2
Chappey, O.3
Wautier, M.-P.4
Guillausseau, P.-J.5
Cao, R.6
Horl, O.7
Stern, D.8
Schmidt, A.M.9
-
19
-
-
0031717894
-
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
-
DOI 10.1038/2012
-
Park L., Raman K. G., Lee K. J., Lu Y., Ferran L. J. Jr., Choe W. S., Stern D., Schmidt A. M., Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nature Medicine 1998 4 9 1025 1031 2-s2.0-0031717894 10.1038/2012 (Pubitemid 28417334)
-
(1998)
Nature Medicine
, vol.4
, Issue.9
, pp. 1025-1031
-
-
Park, L.1
Raman, K.G.2
Lee, K.J.3
Lu, Y.4
Ferran Jr., L.J.5
Choe, W.S.6
Stern, D.7
Schmidt, A.M.8
-
20
-
-
18244381813
-
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
-
DOI 10.1161/01.ATV.0000160342.20342.00
-
Falcone C., Emanuele E., D'Angelo A., Buzzi M. P., Belvito C., Cuccia M., Geroldi D., Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 5 1032 1037 2-s2.0-18244381813 10.1161/01.ATV.0000160342.20342.00 (Pubitemid 40627851)
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, Issue.5
, pp. 1032-1037
-
-
Falcone, C.1
Emanuele, E.2
D'Angelo, A.3
Buzzi, M.P.4
Belvito, C.5
Cuccia, M.6
Geroldi, D.7
-
21
-
-
79960699904
-
Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury
-
2-s2.0-79960699904 10.1016/j.atherosclerosis.2011.05.023
-
Cai X. Y., Lu L., Wang Y. N., Jin C., Zhang R. Y., Zhang Q., Chen Q. J., Shen W. F., Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury. Atherosclerosis 2011 217 2 536 542 2-s2.0-79960699904 10.1016/j.atherosclerosis. 2011.05.023
-
(2011)
Atherosclerosis
, vol.217
, Issue.2
, pp. 536-542
-
-
Cai, X.Y.1
Lu, L.2
Wang, Y.N.3
Jin, C.4
Zhang, R.Y.5
Zhang, Q.6
Chen, Q.J.7
Shen, W.F.8
-
22
-
-
77955013993
-
Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products
-
2-s2.0-77955013993 10.1007/s11010-010-0444-3
-
McNair E. D., Wells C. R., Mabood Qureshi A., Basran R., Pearce C., Orvold J., Devilliers J., Prasad K., Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products. Molecular and Cellular Biochemistry 2010 341 1-2 135 138 2-s2.0-77955013993 10.1007/s11010-010-0444-3
-
(2010)
Molecular and Cellular Biochemistry
, vol.341
, Issue.1-2
, pp. 135-138
-
-
McNair, E.D.1
Wells, C.R.2
Mabood Qureshi, A.3
Basran, R.4
Pearce, C.5
Orvold, J.6
Devilliers, J.7
Prasad, K.8
-
23
-
-
0033603241
-
RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides
-
DOI 10.1016/S0092-8674(00)80801-6
-
Hofmann M. A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M. F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A. M., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999 97 7 889 901 2-s2.0-0033603241 10.1016/S0092-8674(00) 80801-6 (Pubitemid 29375048)
-
(1999)
Cell
, vol.97
, Issue.7
, pp. 889-901
-
-
Hofmann, M.A.1
Drury, S.2
Fu, C.3
Qu, W.4
Taguchi, A.5
Lu, Y.6
Avila, C.7
Kambham, N.8
Bierhaus, A.9
Nawroth, P.10
Neurath, M.F.11
Slattery, T.12
Beach, D.13
McClary, J.14
Nagashima, M.15
Morser, J.16
Stern, D.17
Schmidt, A.M.18
-
24
-
-
2342544788
-
Effect of advanced glycation end products on endotoxin-induced TNF-α, IL-1β and IL-8 in human peripheral blood mononuclear cells
-
Reznikov L. L., Waksman J., Azam T., Kim S.-H., Bufler P., Niwa T., Werman A., Zhang X., Pischetsrieder M., Shaldon S., Dinarello C. A., Effect of advanced glycation end products on endotoxin-induced TNF- α IL-1 β and IL-8 in human peripheral blood mononuclear cells. Clinical Nephrology 2004 61 5 324 336 2-s2.0-2342544788 (Pubitemid 38579018)
-
(2004)
Clinical Nephrology
, vol.61
, Issue.5
, pp. 324-336
-
-
Reznikov, L.L.1
Waksman, J.2
Azam, T.3
Kim, S.-H.4
Bufler, P.5
Niwa, T.6
Werman, A.7
Zhang, X.8
Pischetsrieder, M.9
Shaldon, S.10
Dinarello, C.A.11
-
25
-
-
0029084524
-
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: Potential role of matrix-degrading metalloproteinases and implications for plaque rupture
-
2-s2.0-0029084524
-
Shah P. K., Falk E., Badimon J. J., Fernandez-Ortiz A., Mailhac A., Villareal- Levy G., Fallon J. T., Regnstrom J., Fuster V., Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995 92 6 1565 1569 2-s2.0-0029084524
-
(1995)
Circulation
, vol.92
, Issue.6
, pp. 1565-1569
-
-
Shah, P.K.1
Falk, E.2
Badimon, J.J.3
Fernandez-Ortiz, A.4
Mailhac, A.5
Villareal- Levy, G.6
Fallon, J.T.7
Regnstrom, J.8
Fuster, V.9
-
26
-
-
24144445082
-
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
-
Geroldi D., Falcone C., Emanuele E., D'Angelo A., Calcagnino M., Buzzi M. P., Scioli G. A., Fogari R., Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. Journal of Hypertension 2005 23 9 1725 1729 2-s2.0-24144445082 (Pubitemid 41233433)
-
(2005)
Journal of Hypertension
, vol.23
, Issue.9
, pp. 1725-1729
-
-
Geroldi, D.1
Falcone, C.2
Emanuele, E.3
D'Angelo, A.4
Calcagnino, M.5
Buzzi, M.P.6
Scioli, G.A.7
Fogari, R.8
-
27
-
-
84861460150
-
Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus
-
10.1055/s-0031-1283161
-
Skrha J. Jr., Kalousová M., Svarcová J., Muravská A., Kvasnička J., Landová L., Zima T., Skrha J., Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 2012 120 5 277 281 10.1055/s-0031-1283161
-
(2012)
Experimental and Clinical Endocrinology & Diabetes
, vol.120
, Issue.5
, pp. 277-281
-
-
Skrha Jr., J.1
Kalousová, M.2
Svarcová, J.3
Muravská, A.4
Kvasnička, J.5
Landová, L.6
Zima, T.7
Skrha, J.8
-
28
-
-
34548740746
-
Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins
-
DOI 10.1016/j.freeradbiomed.2007.06.017, PII S0891584907004546
-
Santilli F., Bucciarelli L., Noto D., Cefalù A. B., Davì V., Ferrante E., Pettinella C., Averna M. R., Ciabattoni G., Davì G., Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Free Radical Biology and Medicine 2007 43 9 1255 1262 2-s2.0-34548740746 10.1016/j.freeradbiomed.2007.06.017 (Pubitemid 47429934)
-
(2007)
Free Radical Biology and Medicine
, vol.43
, Issue.9
, pp. 1255-1262
-
-
Santilli, F.1
Bucciarelli, L.2
Noto, D.3
Cefalu, A.B.4
Davi, V.5
Ferrante, E.6
Pettinella, C.7
Averna, M.R.8
Ciabattoni, G.9
Davi, G.10
-
29
-
-
33751171940
-
Suppression of rage as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes
-
2-s2.0-33751171940 10.1161/01.ATV.0000249630.02085.12
-
Cuccurullo C., Iezzi A., Fazia M. L., de Cesare D., Di Francesco A., Muraro R., Bei R., Ucchino S., Spigonardo F., Chiarelli F., Schmidt A. M., Cuccurullo F., Mezzetti A., Cipollone F., Suppression of rage as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 12 2716 2723 2-s2.0-33751171940 10.1161/01.ATV.0000249630.02085.12
-
(2006)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.26
, Issue.12
, pp. 2716-2723
-
-
Cuccurullo, C.1
Iezzi, A.2
Fazia, M.L.3
De Cesare, D.4
Di Francesco, A.5
Muraro, R.6
Bei, R.7
Ucchino, S.8
Spigonardo, F.9
Chiarelli, F.10
Schmidt, A.M.11
Cuccurullo, F.12
Mezzetti, A.13
Cipollone, F.14
-
30
-
-
0035799331
-
High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
-
Ridker P. M., High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001 103 13 1813 1818 2-s2.0-0035799331 (Pubitemid 32291421)
-
(2001)
Circulation
, vol.103
, Issue.13
, pp. 1813-1818
-
-
Ridker, P.M.1
-
31
-
-
33646047719
-
Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography
-
2-s2.0-33646047719 10.1016/j.jacc.2006.01.041
-
Hoffmann U., Moselewski F., Nieman K., Jang I.-K., Ferencik M., Rahman A. M., Cury R. C., Abbara S., Joneidi-Jafari H., Achenbach S., Brady T. J., Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. Journal of the American College of Cardiology 2006 47 8 1655 1662 2-s2.0-33646047719 10.1016/j.jacc.2006.01.041
-
(2006)
Journal of the American College of Cardiology
, vol.47
, Issue.8
, pp. 1655-1662
-
-
Hoffmann, U.1
Moselewski, F.2
Nieman, K.3
Jang, I.-K.4
Ferencik, M.5
Rahman, A.M.6
Cury, R.C.7
Abbara, S.8
Joneidi-Jafari, H.9
Achenbach, S.10
Brady, T.J.11
-
32
-
-
77955544301
-
Inflammation markers in patients with coronary artery disease - Comparison of intracoronary and systemic levels
-
2-s2.0-77955544301 10.1007/s00508-010-1343-z
-
Kirbiš S., Breskvar U. D., Šabovič M., Zupan I., Sinkovič A., Inflammation markers in patients with coronary artery disease-comparison of intracoronary and systemic levels. Wiener Klinische Wochenschrift 2010 122 2 31 34 2-s2.0-77955544301 10.1007/s00508-010-1343-z
-
(2010)
Wiener Klinische Wochenschrift
, vol.122
, Issue.2
, pp. 31-34
-
-
Kirbiš, S.1
Breskvar, U.D.2
Šabovič, M.3
Zupan, I.4
Sinkovič, A.5
|